Fixed-Dose and Co-Packaged Combinations provide novel business opportunities for companies to leverage their existing portfolio of products and intellectual property in addition to providing avenues for strategic partnership with other companies. However, they also offer unique development, regulatory, and commercial challenges. This conference will focus on the practical interplay between combination therapy forefront research, development challenges, and commercial and partnering strategies, as well as the implications for successful market realization.
Conference Highlights:
Determining the Commercial Scope for Combination Therapies in Particular Therapeutic Areas
Achieving Innovative Line Extension and Life-Cycle Management (LCM) Strategies
Intellectual Property Leveraging, Licensing, and Protection
Overcoming Development and Formulation Challenges of Combination Therapies
Emerging Therapeutic Areas for Combinations: Performance to Date and Future Prospects
Understanding Regulatory Hurdles and Variation in International Acceptance
Conference Highlights:
Determining the Commercial Scope for Combination Therapies in Particular Therapeutic Areas
Achieving Innovative Line Extension and Life-Cycle Management (LCM) Strategies
Intellectual Property Leveraging, Licensing, and Protection
Overcoming Development and Formulation Challenges of Combination Therapies
Emerging Therapeutic Areas for Combinations: Performance to Date and Future Prospects
Understanding Regulatory Hurdles and Variation in International Acceptance
